Viveve Medical Inc (VIVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,422 | -4,106 | -12,426 | -8,749 | -5,530 |
| Depreciation Amortization | 45 | 21 | 77 | 57 | 36 |
| Accounts receivable | 4 | -198 | -587 | -233 | 6 |
| Accounts payable and accrued liabilities | 422 | 197 | 1,016 | 685 | 196 |
| Other Working Capital | 2,137 | 1,661 | -800 | -329 | -150 |
| Other Operating Activity | 513 | 376 | 525 | 240 | 370 |
| Operating Cash Flow | $-6,301 | $-2,049 | $-12,195 | $-8,329 | $-5,072 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -137 | -36 | -109 | -48 | -1 |
| Investing Cash Flow | $-137 | $-36 | $-109 | $-48 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,944 | N/A | 2,500 | 2,500 | 1,500 |
| Debt Repayment | -4,833 | -299 | -167 | N/A | N/A |
| Common Stock Issued | 13,898 | 33 | 16,436 | 11,043 | 11,040 |
| Other Financing Activity | 0 | -3 | 0 | 0 | 0 |
| Financing Cash Flow | $19,009 | $-269 | $18,769 | $13,543 | $12,540 |
| Beginning Cash Position | 7,360 | 7,360 | 895 | 895 | 895 |
| End Cash Position | 19,931 | 5,006 | 7,360 | 6,061 | 8,362 |
| Net Cash Flow | $12,571 | $-2,354 | $6,465 | $5,166 | $7,467 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,301 | -2,049 | -12,195 | -8,329 | -5,072 |
| Capital Expenditure | -137 | -36 | -109 | -48 | -1 |
| Free Cash Flow | -6,438 | -2,085 | -12,304 | -8,377 | -5,073 |